Neurology
3 drugs are in development for Fibromyalgia.
- Companies
- 3
- Clinical trials
- 17
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Fibromyalgia pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| AXS-14 | Axsome Therapeutics, Inc. (AXSM) |
Phase 1(1)
| Drug | Company |
|---|---|
| sp-104 | SCILEX HOLDING CO (SCLX) |
Preclinical(1)
| Drug | Company |
|---|---|
| stat-202 | Statera Biopharma, Inc. (CBLI) |
About this indication
Fibromyalgia context
Neurology·MeSH: Fibromyalgia (D005356)
Also known as: Fibromyalgia Fibromyositis Syndrome, Fibromyalgia-Fibromyositis Syndromes, Fibromyalgias, Fibromyositis Fibromyalgia Syndrome, Fibromyositis-Fibromyalgia Syndromes, Fibrositides, Fibrositis, Muscular Rheumatism, Myofascial Pain Syndrome, Diffuse
Frequently asked questions
How many drugs are in development for Fibromyalgia?
BioSniper tracks 3 drugs in development for Fibromyalgia across 3 companies.
How many clinical trials target Fibromyalgia?
There are 17 clinical trials targeting Fibromyalgia tracked by BioSniper.